Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$74.03 USD

74.03
248,079

-0.15 (-0.20%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $74.03 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Company Summary

South Jordan, UT-headquartered Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology.

The company conducts its business via two operating segments: Cardiovascular (which includes Peripheral Intervention or PI, Cardiac Intervention or CI, Custom Procedural Solutions or CPS and Original Equipment Manufacturer or OEM and Endoscopy.

The Cardiovascular segment (97.1% of total FY23 revenues, up 9.7% at constant exchange rate or CER, organic basis) offers a broad line of medical devices used to gain and maintain vascular ...

General Information

Merit Medical Systems, Inc

1600 WEST MERIT PARK WAY

SOUTH JORDAN, UT 84095

Phone: 801-253-1600

Fax: 801-253-1652

Web: http://www.merit.com

Email: mike.piccinino@westwicke.com

Industry Medical - Dental Supplies
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2024
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

4/30/2024

EPS Information

Current Quarter EPS Consensus Estimate 0.71
Current Year EPS Consensus Estimate 3.31
Estimated Long-Term EPS Growth Rate 10.80
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

4/30/2024

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 74.18
52 Week High 85.62
52 Week Low 62.58
Beta 0.89
20 Day Moving Average 321,995.16
Target Price Consensus 91.67

MMSI

% Price Change
4 Week 1.74
12 Week -6.11
YTD -2.34
% Price Change Relative to S&P 500
4 Week 4.88
12 Week -10.18
YTD -8.20
Share Information
Shares Outstanding (millions) 58.06
Market Capitalization (millions) 4,307.23
Short Ratio NA
Last Split Date 5/6/2011
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 22.38
Trailing 12 Months 24.65
PEG Ratio 2.07
EPS Growth
vs. Previous Year 2.53%
vs. Previous Quarter 8.00%
   
Sales Growth
vs. Previous Year 10.60%
vs. Previous Quarter 2.95%
   
Price Ratios
Price/Book 3.56
Price/Cash Flow 15.37
Price / Sales 3.43
ROE
3/31/24 NA
12/31/23 14.63
9/30/23 14.71
ROA
3/31/24 NA
12/31/23 9.19
9/30/23 9.99
Current Ratio
3/31/24 NA
12/31/23 5.45
9/30/23 3.13
Quick Ratio
3/31/24 NA
12/31/23 3.95
9/30/23 1.50
Operating Margin
3/31/24 NA
12/31/23 13.98
9/30/23 14.25
Net Margin
3/31/24 NA
12/31/23 7.51
9/30/23 8.17
Pre-Tax Margin
3/31/24 NA
12/31/23 8.91
9/30/23 9.03
Book Value
3/31/24 NA
12/31/23 20.81
9/30/23 21.30
Inventory Turnover
3/31/24 NA
12/31/23 2.24
9/30/23 2.26
Debt-to-Equity
3/31/24 NA
12/31/23 0.68
9/30/23 0.23
Debt to Capital
3/31/24 NA
12/31/23 40.64
9/30/23 18.67